Mid Atlantic Epilepsy and Sleep Ctr — Bethesda, Maryland

Mid Atlantic Epilepsy and Sleep Ctr is a clinical research site located in Bethesda, Maryland, United States 20817-1807.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid Atlantic Epilepsy and Sleep Ctr has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Generalized Myasthenia Gravis, Secondary Progressive Multiple Sclerosis (SPMS), Relapsing Multiple Sclerosis (RMS).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Atlantic Epilepsy and Sleep Ctr?

Mid Atlantic Epilepsy and Sleep Ctr has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Atlantic Epilepsy and Sleep Ctr conducted?

Mid Atlantic Epilepsy and Sleep Ctr has 4 clinical trials on record, with 4 currently active. Their work covers Generalized Myasthenia Gravis, Secondary Progressive Multiple Sclerosis (SPMS), Relapsing Multiple Sclerosis (RMS).

Is Mid Atlantic Epilepsy and Sleep Ctr accredited by Crixeo Health?

Mid Atlantic Epilepsy and Sleep Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Atlantic Epilepsy and Sleep Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.